Immunodeficiency References
ASCIA HP Immunodeficiency References 2020182.85 KB
Abolhassani, H., Sadaghiani, M. S., Aghamohammadi, A., Ochs, H. D., & Rezaei, N., (2012). Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: Systematic review and meta-analysis. J Clin Immunol, 32(6), 1180-1192. https://doi.org/10.1007/s10875-012-9720-1
Åhlin, A., Fugeläng, J., de Boer, M., Ringden, O., Fasth, A., & Winiarski, J. (2013). Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment. Acta Paediatr, 102(11), 1087-9 https://doi.org/10.1111/apa.12384
Al-Herz, W., Bousfiha, A., Casanova, J. L., Chatila, T., Conley, M. E., Cunningham-Rundles, C., … Tang, M. L. (2014). Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Frontiers in Immunology, 22(5), 162. https://doi.org/10.3389/fimmu.2014.00162
Ameratunga, R., Woon, S. T., Brewerton, M., Koopmans, W., Jordan, A., Brothers, S., & Singh, R. (2011). Primary immune deficiency disorders in the South Pacific: the clinical utility of a customized genetic testing program in New Zealand. Ann N Y Acad Sci, 1238(1), 53-64. https://doi.org/10.1111/j.1749-6632.2011.06238.x
Ameratunga, R., Woon, S. T., Gillis, D., Koopmans, W., & Steele, R. (2013). New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol, 174(2), 203-11. https://doi.org/10.1111/cei.12178
ASCIA-TAPID Consensus Guideline: Diagnosis, management and transplantation of severe combined immunodeficiency in Australia and New Zealand. 2019 www.allergy.org.au/hp/papers/ascia-guidelines-SCID-TAPID
Asia Pacific Immunoglobulins in Immunology Expert Group (APIIEG) (2009) Consensus Recommendations for the use of Immunoglobulin Replacement Therapy in Immune Deficiency. http://www.korektorzdrowia.pl/wp-content/uploads/apiieg_2009.pdf
Berger, M., (2011). Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD. J Clin Immunol, 31 (5), 924-926. https://doi.org/10.1007/s10875-011-9546-2
Bezrodnik, L. Raccio, A., G., Belardinelli, G., Regairaz, L., Ballve, D. D., Seminario, G., … Giovanni, D. D. (2013). Comparative study of subcutaneous versus intravenous IgG replacement therapy in paediatric patients with primary immunodeficiency diseases: A multicentre study in Argentina. J Clin Immunol, 33, 1216-1222. https://doi.org/10.1007/s10875-013-9916-z
Bonilla, F. A., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Hsu, J. T., … Wallace D. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology. (2015). Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol, 136(5). https://doi.org/10.1016/j.jaci.2015.04.049
Chapel, H., Prevot, J., Gaspar, H.B., Espanol, T., Bonilla, F.A., Solis, L., Drabwell, J. & The Editorial Board for Working Party on Principles of Care at IPOPI. (2014). Primary immune deficiencies – principles of care. Front Immunol, (5), 627. https://doi.org/10.3389/fimmu.2014.00627
Cole, T., McLean‐Tooke, A., Loh, R., Quinn, P., Peake, J., Sinclair, J., & Smart, J. (2018). ASCIA transplantation and primary immunodeficiency (TAPID) project. Internal Medicine Journal, 48, Issue S6. https://onlinelibrary.wiley.com/doi/10.1111/imj.48_14077
Cole, T., Pearce, M. S., Cant, A. J., Cale, C. M., Goldblatt, D., & Gennery, A. R. (2013). Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Immunol. 132(5), 1150-5. 10.1016/j.jaci.2013.05.031
EBMT/ESID Guidelines for haematopoietic stem cell transplantation (HSCT) for primary immunodeficiencies HSCT Guidelines. (2017). https://www.ebmt.org/ebmt/documents/esid-ebmt-hsct-guidelines-2017
Gardulf, A. (2007). Immunoglobulin treatment for primary antibody deficiencies: Advantages of the subcutaneous route. Biodrugs. https://pubmed.ncbi.nlm.nih.gov/17402794/
Gaspar, J., Gerritsen, B., & Jones, A., (1998). Immunoglobulin replacement treatment by rapid subcutaneous infusion. Archives of Disease in Childhood, 79 (1), 48-51. http://dx.doi.org/10.1136/adc.79.1.48
Gray, P. E., Namasivayam, M., & Ziegler, J. B. (2012). Recurrent infection in children: when and how to investigate for primary immunodeficiency? J Paediatr Child Health, 48(3), 202-209. https://doi.org/10.1111/j.1440-1754.2011.02080.x
Jolles, S. & Sleasman, J. W., Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a practical approach. (2011). Adv Ther, 28(7), 521-533. https://link.springer.com/content/pdf/10.1007/s12325-011-0036-y.pdf
Kang, E. M., Marciano, B. E., DeRavin, S., Zarember, K. A., Holland, S. M., & Malech, H. L., (2011). Chronic Granulomatous disease: Overview and hematopoietic stem cell transplantation. J Clin Immunol Allergy, 127(6), 1319-1326. https://doi.org/10.1016/j.jaci.2011.03.028
Kirkpatrick, P. & Riminton, S. (2007). Primary immunodeficiency diseases in Australia and New Zealand, J Clin Immunol, 27(5), 517-24. https://doi.org/10.1007/s10875-007-9105-z
Kobrynski, L. (2012). Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases. Biologics:Targets and Therapy, 6, 277-287. https://doi.org/10.2147/btt.s25188
Lingman-Framme, J., & Fasth, A. (2013). Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review. Drugs, 73, 1307-1319. https://doi.org/10.1007/s40265-013-0094-3
Mitchell, R., Nivison-Smith, I., Anazodo, A., Tiedemann, K., Shaw, P., Teague, L. … O’Brien, T.A. (2013). Outcomes of Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency: A Report from the Australian and New Zealand Children’s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Biology of Blood and Marrow Transplantation, 19(3), 338-343. https://doi.org/10.1016/j.bbmt.2012.11.61
Neven, B. & Furrua, F., (2020). Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on behalf of IEWP-EBMT. Front Pediatr https://doi.org/10.3389/fped.2019.00552
Nicolay, U., Haag, S., Eichmann, F., Herget, S., Spruck, D., & Gardulf, A. (2005). Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapy. Quality of Life Research, 14(7), 1683-1691. https://doi.org/10.1007/s11136-005-1746-x
Ochs, H.D., Gupta, S., Kiessling, P., Nicolay, U., Berger, M. & Subcutaneous IgG Study Group. (2006) Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Immunol Allergy, 26 (3), 265-273. https://doi.org/10.1007/s10875-006-9021-7
Picard, C., Gaspar, H. B., Al-Herz, W., Bousfiha, A., Casanova, J., Chatila, T., … Sullivan, K. E. (2017). International Union of Immunological Societies Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol, 38, 96-128. https://link.springer.com/article/10.1007/s10875-017-0464-9
Radinsky S, Bonagura VR. (2003). Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin. J Allergy Clin Immunol, 112, 630-633. https://www.jacionline.org/article/S0091-6749(03)01781-0/pdf
Richards, S., Gennery, A.R., Davies, G., Wong, M., Shaw, P.J., Peake, J., … Cole, T., on behalf of ASCIA Transplantation and Primary Immunodeficiency (TAPID) group. (2020). Diagnosis and management of severe combined immunodeficiency in Australia and New Zealand. Journal of Paediatrics and Child Health, 56, 1508–1513. https://onlinelibrary.wiley.com/doi/10.1111/jpc.15158
Riminton, D. S., Hartung, H. P., & Reddel, S. W. (2011). Managing the risks of immunosuppression. Curr Opin Neurol, 24(3), 217-23. https://doi.org/10.1097/wco.0b013e328346d47d
Seger, R. A. (2010). Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease, Immunol allergy Clin N Am, 30, 195-208. https://doi.org/10.1016/j.iac.2010.01.003
Slade, C. A., Bosco, J., Giang, T. B., Kruse, E., Stirling, R.G., Cameron, P. U., … van Zelm, M. C. (2018). Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults. Front Immunol, https://doi.org/10.3389/fimmu.2018.00694
Soncini, E., Slatter, M. A., Jones, L. B., Hughes, S., Hodges, S., Flood, T. J., … Gennery, A. R. (2009). Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. Br J Haematol. 145(1),73-83. https://doi.org/10.1111/j.1365-2141.2009.07614.x
Stiehm, E.R., Casillas, A.M., Finkelstein, J.Z., Gallagher, K.T., Groncy, P.M., Kobayashi, R.H., … Wakim, M. E. (1998). Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: use of an old method with a new product. J Allergy Clinical Immunol, 101 (6 Pt 1), 848-9. https://doi.org/10.1016/S0091-6749(98)70314-8
Tangye, S., Al-Herz, W., Bousfiha, A., Chatila, T., Cunningham-Rundles, C., Etzoni, A., … Sullivan, K. (2020). Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol, 40, 24-64. https://link.springer.com/article/10.1007%2Fs10875-019-00737-x https://doi.org/10.1007/s10875-020-00763-0.
Uzel, G., Orange, J. S., Poliak, N., Marciano, B. E., Heller, T., & Holland, S., M. (2010). Complications of Tumor Necrosis Factor-± Blockade in Chronic Granulomatous Disease—Related Colitis. Clin Infect Dis, 51(12), 1429–1434. https://doi.org/10.1086/657308
Younger, M. E. M (ed), IDF (Fourth Edition, 2016) Guide for Nurses. Immunoglobulin Therapy for Primary Immunodeficiency Diseases. Immune Deficiency Foundation. https://primaryimmune.org/sites/default/files/publications/IDF-Guide-for-Nurses-4th-Edition.pdf
Younger, M. E., Aro, L., Blouin, W., Duff, C., Epland, K. B., Murphy, E., & Sedlak, D. (2013). Nurse Advisory Committee Immune Deficiency Foundation. Nursing guidelines for administration of immunoglobulin replacement therapy. J Infus Nurs. 36(1), 58-68. https://doi.org/10.1097/NAN.0b013e3182798af8
NOTE: There is a separate ASCIA reference list for Hereditary Angioedema (HAE) publications on the ASCIA website www.allergy.org.au/hp/papers#p4
Content updated October 2020